DXCM Income Statement
Dexcom Inc - Revenue, Expenses & Profit Analysis
Stock Price
$0.00
Market Cap
-
Most Recent Quarter
Period: 2024-12-31(2024-12-31)
Revenue
Total sales from operations
$4.03B
+11.3% YoY
Net Income
Bottom line profit
$576.20M
Earnings Per Share (Diluted)
Net income per share
$1.42
Profitability Metrics
Historical Income Statements
| Period | Revenue | Gross Profit | Operating Income | Net Income | EPS |
|---|---|---|---|---|---|
| 2024-12-31 | $4.03B | - | - | $576.20M | $1.42 |
| 2023-12-31 | $3.62B | - | - | $541.50M | $1.30 |
| 2022-12-31 | $2.91B | - | - | $341.20M | $0.82 |
| 2021-12-31 | $2.45B | - | - | $216.90M | $0.53 |
| 2020-12-31 | $1.93B | - | - | $549.70M | $1.33 |
View Complete Financial Analysis
Full income statements, balance sheets, cash flows, and AI-powered insights
Open Full AnalysisFrequently Asked Questions
What is DXCM's revenue?
DXCM's most recent quarterly revenue was $4.03B, representing a growth of 11.3% year-over-year.
Is DXCM profitable?
DXCM reported a profit of $576.20M in the most recent quarter.
What is DXCM's operating income?
Operating income data is available in the income statement.
What is DXCM's earnings per share (EPS)?
DXCM reported diluted earnings per share of $1.42 in the most recent quarter.
What is DXCM's gross profit margin?
Gross margin data is available in the profitability metrics section.